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1. Introduction 
Slow-reacting substance of anaphylaxis (SRS-A) is 
a primary mediator of immediate-type hypersensitivity 
reactions uch as asthma. It is released together with 
histamine, other primary mediators and prostaglandins, 
and its release was originally described over 30 years 
ago [l] . Since then the roles of histamine and 
prostaglandins in asthma nd anaphylaxis have been 
extensively studied. It has been found, by the develop- 
ment of chemical antagonists and later by the syn- 
thesis of pure mediators, that histamine accounts for 
only part of the bronchoconstriction f anaphylaxis 
or asthma, and that while some prostaglandins are 
bronchoconstrictors, their main action seems to be as 
modulators of the other agonists [2,3] . 
Consequent on these findings the study of SRS-A 
(the remaining major bronchoconstrictor substance 
associated with the above immunological reactions) 
has taken on a new relevance and sense of urgency. 
To date, however, major difficulties with purification 
and structure lucidation of SRS-A have severely 
retarded an understanding of the biological signifi- 
cance of this important mediator. 
At various times over some 20 years of study by 
several groups, SRS-A has been described in the 
literature as a hydroxy acid, a ‘low molecular weight 
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lipid’, ‘a carboxylic acid with hydroxyl groups and 
one or more double bonds’ [4,5] and more recently 
as a compound containing ‘a sulphate ster group’ 
[6] . In fact, the chemical evidence for all of these 
generalisations is not entirely conclusive and reflects 
the difficulties encountered in the attempted eter- 
mination of the structure of small quantities of impure 
biologically active substances. 
We describe here an improved purification proce- 
dure which will yield highly purified SRS-A as judged 
by spectroscopic methods. This new procedure creates 
the possibility of structure determination, together 
with a re-examination f the pharmacological proper- 
ties previously studied using only partially purified 
material. 
2. Materials and methods 
2.1. Guinea pigs 
Guinea pigs (Dunkin Hartley strain, either sex) 
2502300 g were sensitised using ovalbumin [7] 
(Sigma grade II). After 21 days the animals were killed 
and their lungs perfused for 15 min with Tyrode 
solution containing 1 pg/ml of indomethacin. The 
lungs were then challenged with 10 mg ovalbumin 
(Sigma grade III) and the effluent collected on ice 
over a period of 10 min [2] . Activated charcoal was 
added to the crude effluent (0.25 g/l00 ml), which 
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was then shaken and centrifuged at 2000 X g for 
20 min. The supernatant was discarded and the char- 
coal washed twice with 80% ethanol (80 mg/lOO ml 
effluent). The washings, containing SRS-A activity, 
were then rotary evaporated at 35°C and freeze-dried. 
2.2. Gel filtration 
This was carried out in a column (180 X 1 .O cm) 
of Cl 5 Sephadex developed in water/methanol/ 
ammonia (0.880) (40/40/20, v/v/v) and monitored 
at 275 nm on a Cecil Spectrophotometer. 
2.3. Electrophoresis 
This was performed on DEAE and SC 81 paper 
(Whatman Ltd.) in pH 6.5 pyridine acetate buffers, at 
3 kV for 1 h. Samples for bioassay were eluted with 
the solvent system used for gel filtration (see above). 
2.4. Acid extraction 
The crude ex-Cl5 SRS-A was rotary evaporated, 
freeze-dried and taken up in pH 2.8 acetic acid solu- 
tion; it was extracted twice into ether and the ether 
phase was dried under nitrogen and finally on a 
vacuum pump. 
2.5. High pressure liquid chromatography 
This was carried out on a Waters instrument, using 
a Bondapak Cl8 column eluted with water followed 
by a gradient o 100% methanol. 
2.6. Ultraviolet spectra 
These were obtained for the purified SRS-A frac- 
tion and for standard compounds on a Unicam SP 800 
spectrophotometer. 
2.7. Assay of SRS-A activity 
At all stages of purification, fractions were assayed 
for SRS-A activity on guinea-pig leum [2]; slow- 
reacting substance of anaphylaxis (SRS-A) was 
quantitated in arbitrary units defined in terms of the 
activity of an initial batch of partially purified material. 
0.068 i: 0.004 units SRS-A are equivalent to 2 units 
SRS-A measured in terms of histamine [8]. 
3. Results and discussion 
The problems of purifying small quantities of 
biologically active molecules are three-fold: 
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(i) Losses by absorption and adsorption. 
(ii) Destruction by acid, base, nucleophiles or 
electrophiles. 
(iii) The sample can only be monitored by its biological 
activity and quantitated in units. 
The following purification scheme reported here 
has been designed to minimise losses via (i) and (ii) 
above, but at the same time to maximise the physical 
data relevant to the structure of SRS-A. 
The SRS-A is always observed to elute from a G15 
column together with material absorbing strongly at 
275 nm; this ultraviolet active material contains 
tyrosine and phenylalanine, thus giving an indication 
of the low molecular weight of SRS-A. The gel data 
would suggest mol. wt 200-400 (allowing for any 
aromaticity in the SRS-A structure). 
Following the gel step we have developed two 
alternative pathways for further purification involving 
either electrophoresis ororganic solvent extraction 
prior to high pressure liquid chromatography. 
Electrophoresis was chosen following the description 
of SRS-A as an acidic substance [4]. It was found 
that activity could not be recovered from normal 
Whatman No. 1 or 3MM papers, but could be eluted 
from DEAE-treated paper, and from SG 81 (silica- 
treated) paper in reasonable (>60%) yields. SRS-A 
runs towards the anode with a mobility relative to 
aspartic acid of 0.27. This mobility would suggest a 
mass of 500-1000 for SRS-A, but the behaviour on 
paper may be anomalous for other reasons, e.g., 
binding to the paper, and thus the gel data is believed 
to be a more reliable estimate. Organic extraction of 
SRS-A into acidified ether has been reported [8]. In 
our hands we find that extraction into ether from 
pH 2.8 acetic acid, following the gel filtration, gives 
overall yields in the ether layer of greater than 95%, 
with no activity left in the aqueous layer. Extraction 
at earlier stages in the purification meets with lesser 
success, and indeed the attempted extraction of lung 
effluent failed, the activity remaining in the aqueous 
phase. We interpret our high recovery to mean that 
the ex-G 15 SRS-A preparation isalready more pure 
than reported [6]. High pressure liquid chromatog- 
raphy: As the final purification step leading to (as 
far as we can determine) absolutely pure SRS-A we 
have developed an important procedure using high 
pressure liquid chromatography (HPLC). 
In this system two regions of activity are recovered 
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Fig.1. High pressure liquid chromatography profile of ether- 
extracted guinea-pig SRS-A. A Bondapak C,, column, 
developed in water:methanol was used and the effluent 
monitored at 254 nm and 280 nm. All fractions were assayed 
for SRS-A activity. 
from the column (A and B in fig.1) and indeed multiple 
activities for chromatographed SRS-A have been 
reported [lo] . We interpret his as being due to the 
presence of a protonated and an unprotonated form 
of the same material. We have supported this con- 
clusion by rechromatographing theactive material 
eluted first from the column (B) which we assigned 
to unprotonated SRS-A. After acidification we now 
observe that this material chromatographs to give the 
major region of activity eluting much later from the 
column at a position corresponding with A in fig. 1, 
i.e., assigned to protonated SRS-A. This ability to 
move the elution position of SRS-A on protonation 
can be used in a double purification step running 
unprotonated and then protonated SRS-A. 
From this behaviour it appears likely that previous 
assignments of multiply active forms of SRS-A are 
due to the different physico-chemical properties of 
protonated/unprotonated SRS-A. 
It should be noted that the SRS-A activity as 
found by bioassay coincides exactly with the small 
ultraviolet absorption at 280 nm and 254 nm indicated 
in fig.1, and that this material is the last to be eluted 
from the column. The relative purity of SRS-A is self- 
evident from the accompanying ultraviolet race 
(tig.1) (i.e., a symmetrical u traviolet race at 280 nm 
and 254 nm). The purity is further emphasised by
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Fig.2. (a) Ultraviolet absorption spectrum of highly purified 
SRS-A (fraction A, fig.1) in methanol; 300 units/ml, 10 mm 
pathlength. (b) Ultraviolet absorption spectrum of SRS-A 
taken from [ 41. 
comparing the complete ultraviolet spectrum (fig2a) 
with [4] (fig.2b). 
Our spectrum suggests hat the majority of ultra- 
violet activity previously assigned to SRS-A derives 
from an impurity. We find that SRS-A in methanol as 
a h max at 279 nm (consistent with certain aromatics 
and conjugated chromophores). It has been suggested 
that SRS-A may be derived from arachidonic acid 
[ 1 l] and therefore may be related to the prostaglandins 
and thromboxanes [ 121; however, examination of 
the ultraviolet spectra of some products of both the 
cycle-oxygenase and lipoxygenase pathways indicates 
no close relationship with SRS-A. 
4. Conclusion 
An advanced purification technique has been 
described for SRS-A and evidence of high purity 
demonstrated. Suspected multiple forms of SRS-A 
are seen to be protonated or unprotonated versions 
of the same material, protonation probably taking 
place at a carboxyl group. The full ultraviolet spectrum 
of SRS-A is given, clearly discounting some classes of 
molecule for the SRS-A structure. Structural work on 
larger quantities of SRS-A is now progressing using 
mass pectrometric and nuclear magnetic resonance 
techniques. 
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